Catechol Oxidase-Like Oxidation Chemistry
of the 1–20 and 1–16 Fragments of Alzheimer’s Disease-Related β-Amyloid Peptide:
Their Structure-Activity Correlation and the Fate of Hydrogen Peroxide‡
da Silva, G. F. Z.; Tay, W. M. and Ming,
L.-J.
J. Biol. Chem. 2005, 280, 16601-16609
The Cu+2 complexes of the 1-16 and the 1-20 fragments
of the Alzheimer’s disease-related β-amyloid peptide (CuAβ) show significant
oxidative activities toward a catechol-like substrate trihydroxylbenzene
and plasmid DNA cleavage. The latter reflects possible oxidative stress
to biological macromolecules, yielding supporting data to the pathological
role of these soluble Aβ fragments. The former exhibits enzyme-like
kinetics and is dependent on [H2O2],
exhibiting kcat of 0.066 s–1 (6000 folds higher
than the reaction without CuAβ) and kcat/Km
of 37.2 M–1s–1
under saturating [H2O2]
of ~0.24%. This kinetic profile is consistent with metal-centered redox
chemistry for the action of CuAβ. A mechanism is proposed by the use
of the catalytic cycle of dinuclear catechol oxidase as a working model.
Trihydroxylbenzene is also oxidized by CuAβ aerobically without H2O2,
affording rate constants of 6.50 × 10–3 s–1
and 3.25 M–1s–1.
This activity is also consistent with catechol oxidase action in the absence
of H2O2, wherein
the substrate binds and reduces the Cu2+ center
first, followed by O2 binding to afford the μ-η2:η2-peroxo
intermediate which oxidizes a second substrate to complete the catalytic
cycle. A tetragonally distorted octahedral metal coordination sphere
with three coordinated His side chains and some specific H-bonding interactions
is concluded from the electronic spectrum of CuAβ, hyperfine-shifted 1H
NMR spectrum of CoAβ, and molecular mechanics calculations. The results
presented here are expected to add further insight into the chemistry of
metallo-Aβ which may assist better understanding of the neuropathology of
Alzheimer’s disease.
‡ LJM dedicates this article to his mother
and to Dr. Shwu-Yeng Lin, who with great patience and kindness have been
caring for their beloved better halves through some very difficult times
of “losing minds”. GFZS dedicates this article to Ayres Baptista Mello
and family, whose struggle with Alzheimer's disease has fueled the author's
desire in gaining better understanding of the mechanisms of this disease
at the molecular level.
(reprint
in pdf)